Progressive Therapeutics (PTI) is a life sciences company developing novel psychoactive therapeutics. PTI is pioneering the next frontier of mental health solutions for the women’s healthcare market as well as multiple indications for broader mental health needs. Their flag solutions is a low dose Ketamine lozenge that helps relieve menstrual symptoms. The company was founded by Phil Wolfson, well-regarded scientists working with Ketamine and the author of the Ketamine Papers.